Pricing Log in Create free account

Conexeu Sciences Inc. (CNXU) vs Cardiff Oncology, Inc. (CRDF)

Conexeu Sciences Inc. and Cardiff Oncology, Inc. are both Biotechnology companies. Conexeu Sciences Inc. is the larger, with a market value of $65.4M against $58.8M — 1.1× the size. Conexeu Sciences Inc. has the higher net margin (0.00% vs −7,889.0%) and the lower return on invested capital (−234.6% vs 0.00%). Across the 12 metrics below, Conexeu Sciences Inc. leads on 6 and Cardiff Oncology, Inc. on 6.

Valuation

Metric CNXU CRDF Biotechnology median
P/E n/m n/m 10.26
P/S n/m 102.33 9.18
P/B 9.64 1.96 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 37.15 8.98
Earnings yield (29.81%) (78.95%) (34.89%)
Free cash flow yield (18.82%) (78.76%) (24.52%)

Profitability

Metric CNXU CRDF Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (8,320.08%) 0.00%
Net margin 0.00% (7,888.98%) 0.00%
Free cash flow margin 0.00% (8,059.45%) 0.00%
Return on equity (458.40%) (94.14%) (50.12%)
Return on assets (354.37%) (70.89%) (45.60%)
Return on invested capital (234.60%) 0.00% 0.00%

Growth

Metric CNXU CRDF Biotechnology median
Revenue growth (TTM) — (6.79%) 6.26%
EPS growth (last fiscal year) (342.80%) 27.37% 29.88%
Revenue growth, 5-year CAGR — 10.13% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CNXU CRDF Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.31 3.30 4.89
Net debt to EBITDA 1.23 1.18 1.01

Dividend

Metric CNXU CRDF Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNXU CRDF Biotechnology median
Market cap 65.36m 58.76m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack